DavoodVafaiMD

Oncology • Rancho Mirage, CA

Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Eisenhower health medical oncologist codirector lung cancer program. Special fellowship in myeloma leukemia lymphoma

Join to view full profile

Dr. Vafai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vafai's full profile

Already have an account?

Office
40075 Bob Hope Dr
Rancho Mirage, CA 92270
Phone+1 760-341-3688

Fax+1 760-341-8992

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1993 - 1995
Tehran University of Medical Sciences School of MedicineClass of 1981

Certifications & Licensure

CA State Medical License 1991 - 2025
LA State Medical License 1999 - 2000
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Start of enrollment: 2015 May 07
Active, not recruiting
Phase 2, Phase 3

Publications & Presentations

PubMed

38 citations
Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients
Sai-Hong Ignatius Ou, Leora Horn, Marcelo Rocha Cruz, Davood Vafai, Christine M. Lovly
Lung Cancer. 2017-09-01
13 citations
Genomic Profiling of Circulating Tumor DNA in Relapsed EGFR-mutated Lung Adenocarcinoma Reveals an Acquired FGFR3-TACC3 Fusion.
Justin M. Allen, Alexa B. Schrock, Rachel L. Erlich, Vincent A. Miller, Philip J. Stephens
Clinical Lung Cancer. 2017-05-01
28 citations
Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials.
Franco M. Muggia, D. Vafai, Ronald B. Natale, V. Israel, S. Zaretsky
Seminars in Oncology. 1995-08-01

Other Languages

Farsi